NVRO logo

Nevro (NVRO) Company Overview

Profile

Full Name:

Nevro Corp.

Sector:

Healthcare

Industry:

Medical Devices

Country:

United States

IPO:

November 6, 2014

Indexes:

Not included

Website:

http://nevro.com

Description:

Nevro Corp. is a global medical equipment company focused on providing innovative products that improve the quality of life for patients suffering from chronic pain. The company has developed the Senza spinal cord stimulation system, a scientifically based neuromodulation platform for treating chronic pain, and has also launched the latest product platform, Senza Omnia. The company launched Senza in the United States in May 2015, in some European countries since November 2010, and in Australia since August 2011. Currently, Senza is covered by all major insurance companies, and the patented hf10 therapy without sensory disturbances outperforms traditional spinal cord stimulation therapy, with hf10 therapy being nearly twice as successful in treating back pain and 1.5 times more successful in treating leg pain compared to traditional spinal cord stimulation therapy.

Key Details

Price

$5.81

Market Cap

$217.71 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$408.52 M(-3.92% YoY)

Annual EPS

-

PE Ratio

-

Annual ROE

-49.11%

Annual Debt To Equity

1.09

Beta

2.20

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 28, 2025

Recent annual earnings:

Feb 28, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 6, 2014

Analyst ratings

Recent major analysts updates

Feb 7, 25 Piper Sandler
Neutral
Feb 7, 25 Canaccord Genuity
Hold
Dec 18, 24 Truist Securities
Hold
Dec 11, 24 Wells Fargo
Equal-Weight
Dec 11, 24 Citigroup
Neutral
Dec 9, 24 Canaccord Genuity
Hold
Dec 2, 24 Morgan Stanley
Underweight
Nov 12, 24 RBC Capital
Sector Perform
Nov 12, 24 Piper Sandler
Underweight
Nov 12, 24 JMP Securities
Market Perform

Screeners with NVRO included

Growing Shares Outstanding
US stocks
Stocks with high beta
Stocks below SMA 200
Stocks recommended to hold
Stocks above SMA 50
Healthcare sector
All stocks
Small cap stocks
Moving average channel strategy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$5.81
NVRO price is $5.81

Price All-time High

$184.34
NVRO price is currently -96.85% below its historical high of $184.34

Price Analysts Target

$5.85
NVRO price is currently -0.68% lower than the consensus analysts' forecast

Price Most Recent Change

+1.04%
NVRO price was up +1.04% on Mar 5, 2025

Price YTD Change

+64.12%
NVRO price is up +64.12% since January 1st

Price 3-Year Change

-91.64%
NVRO price is down -91.64% over the past 3 years

Market cap

Market Cap

$217.71 M
NVRO market capitalization is $217.71 million

Market Cap 3-Year Change

-91.06%
NVRO market capitalization is down -91.06% over the past 3 years

Market Cap All-time High

$6.35 B
NVRO market capitalization is currently -96.57% below its historical high of $6.35 billion

Market Cap Sector Rank

56.63%
NVRO market capitalization is higher than 56.63% of companies in Healthcare sector

Technical

Beta

2.20
NVRO beta is 2.20

200-day SMA

$6.17
NVRO price is currently -5.81% below its 200-day simple moving average

14-day RSI

71.77
NVRO 14-day relative strength index is 71.77

30-day Relative Volume

1.36
NVRO 30-day relative volume is 1.36

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$408.52 M
NVRO annual revenue is $408.52 million

Annual Revenue Analysts Estimate

$415.38 M
NVRO annual revenue is currently -1.65% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

-3.92%
NVRO annual revenue is down -3.92% year-on-year

Annual Revenue Sector Rank

73.22%
NVRO annual revenue is higher than 73.22% of companies in Healthcare sector

Profit

Annual Gross Profit

$269.53 M
NVRO annual gross profit is $269.53 million

Annual Gross Margin

65.98%
NVRO annual gross profit margin is 65.98%

Annual Operating Profit

-$94.70 M
NVRO annual operating income is -$94.70 million

Annual Operating Margin

-23.18%
NVRO annual operating profit margin is -23.18%

Annual Net Income

-$113.44 M
NVRO annual net profit is -$113.44 million

Annual Net Margin

-
NVRO annual net profit margin value is unknown

EPS

Annual EPS

-
NVRO annual earnings per share value is unknown

Annual EPS Analysts Estimate

-$2.37
NVRO annual earnings per share is currently equal to the consensus analysts' forecast

Annual EPS 1-Year Change

-
NVRO annual earnings per share 1-year change is unknown

Annual EPS Sector Rank

-
NVRO annual earnings per share is unknown

ROA & ROE

Annual ROA

-20.48%
NVRO annual return on assets is -20.48%

Annual ROE

-49.11%
NVRO annual return on equity is -49.11%

EBIT & EBITDA

Annual EBIT

-$85.46 M
NVRO annual earnings before interest & taxes is -$85.46 million

Annual EBITDA

-$67.70 M
NVRO annual EBITDA is -$67.70 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
NVRO price to earnings ratio value is unknown

PE Ratio Sector Rank

-
NVRO price to earnings ratio is unknown

PB Ratio

PB Ratio

1.05
NVRO price to book ratio is 1.05

PB Ratio Sector Rank

44.55%
NVRO price to book ratio is higher than 44.55% of companies in Healthcare sector

PS Ratio

PS Ratio

0.53
NVRO price to sales ratio is 0.53

PS Ratio Sector Rank

15.58%
NVRO price to sales ratio is higher than 15.58% of companies in Healthcare sector

Enterprise value

Enterprise Value

$374.33 M
NVRO enterprise value is $374.33 million

Enterprise Value Sector Rank

64.44%
NVRO enterprise value is higher than 64.44% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-8.45
NVRO EV/EBITDA is -8.45

EV/EBITDA Sector Rank

15.21%
NVRO EV/EBITDA is higher than 15.21% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

4.62
NVRO annual current ratio is 4.62

Annual Quick Ratio

3.62
NVRO annual quick ratio is 3.62

Leverage

Annual Debt To Equity

1.09
NVRO annual debt to equity ratio is 1.09

Annual Interest Coverage Ratio

-3.18
NVRO annual interest coverage ratio is -3.18

Risk & Stability

Piotroski F-Score

2
NVRO piotroski f-score is 2

Altman Z-Score

-0.61
NVRO altman z-score is -0.61

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$553.84 M
NVRO annual total assets is $553.84 million

Annual Non Current Assets

$77.84 M
NVRO annual long term assets is $77.84 million

Annual Current Assets

$476.00 M
NVRO annual total current assets is $476.00 million

Annual Cash & Cash Equivalents

$94.54 M
NVRO annual cash & cash equivalents is $94.54 million

Equity

Annual Book Value

$206.60 M
NVRO annual book value is $206.60 million

Annual Working Capital

$373.06 M
NVRO annual working capital is $373.06 million

Liabilities

Annual Total Liabilities

$322.83 M
NVRO annual total liabilities is $322.83 million

Annual Total Long Term Liabilities

$219.89 M
NVRO annual total long term liabilities is $219.89 million

Annual Current Liabilities

$102.94 M
NVRO annual total current liabilities is $102.94 million

Annual Accounts Payable

$24.46 M
NVRO annual accounts payable is $24.46 million

Debt

Annual Total Debt

$251.16 M
NVRO annual total debt is $251.16 million

Annual Total Debt 1-Year Change

+16.22%
NVRO annual total debt is up +16.22% year-on-year

Annual Long Term Debt

$213.19 M
NVRO annual long term debt is $213.19 million

Annual Short Term Debt

$37.97 M
NVRO annual short term debt is $37.97 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$503.22 M
NVRO annual total expenses is $503.22 million

Annual Operating Expenses

$364.23 M
NVRO annual total operating expenses is $364.23 million

Annual Cost Of Goods Sold

$138.99 M
NVRO annual cost of goods sold is $138.99 million

Annual SGA

$309.77 M
NVRO annual SGA is $309.77 million

Annual D&A

$14.11 M
NVRO annual depreciation & amortization is $14.11 million

Annual Interest Expense

$26.89 M
NVRO annual interest expense is $26.89 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$19.44 M
NVRO annual cash flow from operations is -$19.44 million

Annual CFO 1-Year Change

+66.96%
NVRO annual cash flow from operations is up +66.96% year-on-year

Annual CFI

$14.63 M
NVRO annual cash flow from investing activities is $14.63 million

Annual CFI 1-Year Change

+303.04%
NVRO annual cash flow from investing activities is up +303.04% year-on-year

Annual CFF

-$4.21 M
NVRO annual cash flow from financing activities is -$4.21 million

Annual CFF 1-Year Change

-108.49%
NVRO annual cash flow from financing activities is down -108.49% year-on-year

Free CashFlow

Annual FCF

-$29.23 M
NVRO annual free cash flow is -$29.23 million

Annual FCF 1-Year Change

+56.65%
NVRO annual free cash flow is up +56.65% year-on-year

CAPEX

Annual CAPEX

$9.79 M
NVRO annual capital expenditures is $9.79 million

Annual CAPEX 1-Year Change

+13.87%
NVRO annual capital expenditures is up +13.87% year-on-year

Institutional Ownership

Similar stocks

AMRN logo
Amarin (AMRN)
CRDF logo
Cardiff Oncology (CRDF)
YMAB logo
Y-mAbs Therapeutics (YMAB)
INGN logo
Inogen (INGN)
LFCR logo
Lifecore Biomedical (LFCR)
LFMD logo
LifeMD (LFMD)
Performant Healthcare (PHLT)
ELMD logo
Electromed (ELMD)
TNGX logo
Tango Therapeutics (TNGX)

FAQ

  • What is the ticker symbol for Nevro?
  • Does Nevro pay dividends?
  • What sector is Nevro in?
  • What industry is Nevro in?
  • What country is Nevro based in?
  • When did Nevro go public?
  • Is Nevro in the S&P 500?
  • Is Nevro in the NASDAQ 100?
  • Is Nevro in the Dow Jones?
  • When was Nevro's last earnings report?
  • When does Nevro report earnings?
  • Should I buy Nevro stock now?

What is the ticker symbol for Nevro?

The ticker symbol for Nevro is NYSE:NVRO

Does Nevro pay dividends?

No, Nevro does not pay dividends

What sector is Nevro in?

Nevro is in the Healthcare sector

What industry is Nevro in?

Nevro is in the Medical Devices industry

What country is Nevro based in?

Nevro is headquartered in United States

When did Nevro go public?

Nevro's initial public offering (IPO) was on November 6, 2014

Is Nevro in the S&P 500?

No, Nevro is not included in the S&P 500 index

Is Nevro in the NASDAQ 100?

No, Nevro is not included in the NASDAQ 100 index

Is Nevro in the Dow Jones?

No, Nevro is not included in the Dow Jones index

When was Nevro's last earnings report?

Nevro's most recent earnings report was on Feb 28, 2025

When does Nevro report earnings?

The date for Nevro's next earnings report has not been announced yet

Should I buy Nevro stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions